Scenarios that move ALGS
Aligos Therapeutics, Inc. - Common stock
Scenarios that move ALGS: 1 analysis, 0 positive, 1 negative.
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▼ · impact -22 · confidence low · horizon quarters
Aligos Therapeutics, Inc. - Common stock
Scenarios that move ALGS: 1 analysis, 0 positive, 1 negative.